how many doses each country bought and how many received

The First Nation agreed on its own BioNtech / Pfizer (30 million) and CureVac (20 million), and on the part of the EU, it has been agreed with BioNtech / Pfizer (64 million), Moderna (50.5 million), AstraZeneca (56.3 million), Johnson & Johnson (36.7 million) and CureVac (54.1 million).

The German health authorities have thus acquired 311.6 million, but to date they only have 12.4 million in their possession from the companies BioNtech / Pfizer (8.7 million), AstraZeneca (3 million) and Moderna ( 700 thousand).

Like the UK contracted the impressive sum of 421 million doses for its more than 66.65 million inhabitants by setting promises with Oxford-AstraZeneca (100 million), Pfizer-BioNTech (4 million), Moderna (17 million), Novavax (60 million), Janssen (30 million), GlaxoSmithKline-Sanofi (60 million), Valneva (100 million) and CureVac (50 million), but so far 26.5 million have arrived.

In the South American region, Uruguay, which began its vaccination campaign in early March, acquired 5.25 million via Sinovac (1.75 million), Pfizer-BioNTech (2 million) and 1.5 million from the Covax fund (possibly AstraZeneca) although the report explains that the vaccination process has about 1.85 million.

Brazil, plunged into a serious health crisis, is the country that established the most contractual links at that time and purchased some 561.9 million vaccines: AstraZeneca (214.4 million), Sinovac (100 million), Pfizer / BioNTech (100 million), Janssen (38 million), Bharat Biotech (20 million) Sputnik V (47 million but 37 were bought by the governors of the North-East) the COVAX fund will send 42.5 million.

Despite this multiplicity of options, the government of Jair Bolsonaro has to its credit only 20.65 million.

For its part, Chile ordered the total of 36 million by purchasing from Pfizer-BioNTech (10 million), Sinovac (10 million) and AstraZeneca, Johnson & Johnson and the COVAX platform (16 million in total) but just over 27%, 10,714,300 (Sinovac -10 million- and Pfizer / BioNtech -714,300-) arrived at their deposits.

United States, which has National Laboratories, closed for around 700 million with Pfizer (300 million), Moderna (300 million) and Johnson and Johnson (100 million) and at the moment the campaign has 135,847,835 doses.

The full report of the Chancellery